385 related articles for article (PubMed ID: 25385446)
1. Interethnic differences in pharmacokinetics of antibacterials.
Tsai D; Jamal JA; Davis JS; Lipman J; Roberts JA
Clin Pharmacokinet; 2015 Mar; 54(3):243-60. PubMed ID: 25385446
[TBL] [Abstract][Full Text] [Related]
2. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Roberts JA; Lipman J
Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic issues for antibiotics in the critically ill patient.
Roberts JA; Lipman J
Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
[TBL] [Abstract][Full Text] [Related]
5. Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.
Landersdorfer CB; Bulitta JB; Kinzig M; Holzgrabe U; Sörgel F
Clin Pharmacokinet; 2009; 48(2):89-124. PubMed ID: 19271782
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial-induced nephrotoxicity in the newborn.
Fanos V; Cataldi L
Drug Saf; 1999 Mar; 20(3):245-67. PubMed ID: 10221854
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directions.
Touw DJ; Vinks AA; Mouton JW; Horrevorts AM
Clin Pharmacokinet; 1998 Dec; 35(6):437-59. PubMed ID: 9884816
[TBL] [Abstract][Full Text] [Related]
8. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
Chen ML
Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
[TBL] [Abstract][Full Text] [Related]
9. Dosage adjustments for antibacterials in obese patients: applying clinical pharmacokinetics.
Bearden DT; Rodvold KA
Clin Pharmacokinet; 2000 May; 38(5):415-26. PubMed ID: 10843460
[TBL] [Abstract][Full Text] [Related]
10. Commonly used antibacterial and antifungal agents for hospitalised paediatric patients: implications for therapy with an emphasis on clinical pharmacokinetics.
Singh J; Burr B; Stringham D; Arrieta A
Paediatr Drugs; 2001; 3(10):733-61. PubMed ID: 11706924
[TBL] [Abstract][Full Text] [Related]
11. Continuous versus intermittent intravenous administration of antibacterials with time-dependent action: a systematic review of pharmacokinetic and pharmacodynamic parameters.
Kasiakou SK; Lawrence KR; Choulis N; Falagas ME
Drugs; 2005; 65(17):2499-511. PubMed ID: 16296874
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.
Pea F
Clin Pharmacokinet; 2018 Feb; 57(2):177-189. PubMed ID: 28639230
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.
Di Paolo A; Gori G; Tascini C; Danesi R; Del Tacca M
Clin Pharmacokinet; 2013 Jul; 52(7):511-42. PubMed ID: 23605634
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of linezolid in critically ill patients.
Sazdanovic P; Jankovic SM; Kostic M; Dimitrijevic A; Stefanovic S
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):595-600. PubMed ID: 27020789
[TBL] [Abstract][Full Text] [Related]
15. Principles of antibacterial dosing in continuous renal replacement therapy.
Choi G; Gomersall CD; Tian Q; Joynt GM; Freebairn R; Lipman J
Crit Care Med; 2009 Jul; 37(7):2268-82. PubMed ID: 19487930
[TBL] [Abstract][Full Text] [Related]
16. Intrapulmonary pharmacokinetics of antibacterial agents: implications for therapeutics.
Chiu LM; Amsden GW
Am J Respir Med; 2002; 1(3):201-9. PubMed ID: 14720058
[TBL] [Abstract][Full Text] [Related]
17. Relationship of quantitative structure and pharmacokinetics in fluoroquinolone antibacterials.
Cheng D; Xu WR; Liu CX
World J Gastroenterol; 2007 May; 13(17):2496-503. PubMed ID: 17552035
[TBL] [Abstract][Full Text] [Related]
18. Effects of obesity on pharmacokinetics implications for drug therapy.
Cheymol G
Clin Pharmacokinet; 2000 Sep; 39(3):215-31. PubMed ID: 11020136
[TBL] [Abstract][Full Text] [Related]
19. Oral Ciprofloxacin Pharmacokinetics in Healthy Mexican Volunteers and Other Populations: Is There Interethnic Variability?
Tolentino-Hernández SJ; Cruz-Antonio L; Pérez-Urizar J; Cabrera-Fuentes HA; Castañeda-Hernández G
Arch Med Res; 2020 Apr; 51(3):268-277. PubMed ID: 32143939
[TBL] [Abstract][Full Text] [Related]
20. High dose treatment with antibiotics in cystic fibrosis--a reappraisal with special reference to the pharmacokinetics of beta-lactams and new fluoroquinolones in adult CF-patients.
Sörgel F; Stephan U; Wiesemann HG; Gottschalk B; Stehr C; Rey M; Böwing HB; Dominick HC; Geldmacher von Mallinckrodt M
Infection; 1987; 15(5):385-96. PubMed ID: 3319914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
